Gene · 239
Papers2,360
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,360
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. | World J Clin Cases | 2021 | 34734046 | PubTator, text mining | PubMed |
| Plasma Concentration of 12-Hydroxyeicosatetraenoic Acid, Single Nucleotide Polymorphisms of 12-Lipooxygenase Gene and Vaso-Occlusion in Sickle Cell Disease. | Front Genome Ed | 2021 | 34713264 | PubTator, text mining | PubMed |
| Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis. | Int J Mol Sci | 2021 | 34681927 | PubTator, text mining | PubMed |
| Effects of Nutrients on Platelet Function: A Modifiable Link between Metabolic Syndrome and Neurodegeneration? | Biomolecules | 2021 | 34680088 | PubTator, text mining | PubMed |
| STAT1: a novel candidate biomarker and potential therapeutic target of the recurrent aphthous stomatitis. | BMC Oral Health | 2021 | 34649540 | PubTator, text mining | PubMed |
| Exploring Diagnostic Biomarkers and Comorbid Pathogenesis for Osteoarthritis and Metabolic Syndrome via Bioinformatics Approach. | Int J Gen Med | 2021 | 34616175 | PubTator, text mining | PubMed |
| Novel Rotational Combination Regimen of Skin Topicals Improves Facial Photoaging: Efficacy Demonstrated in Double-Blinded Clinical Trials and Laboratory Validation. | Front Med (Lausanne) | 2021 | 34604259 | PubTator, text mining | PubMed |
| Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer. | J Oncol | 2021 | 34594380 | PubTator, text mining | PubMed |
| MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation. | J Pers Med | 2021 | 34575699 | PubTator, text mining | PubMed |
| Thousands of CpGs Show DNA Methylation Differences in ACPA-Positive Individuals. | Genes (Basel) | 2021 | 34573331 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in Diseases, Longevity, and Treatment Resistance: Tuning Mitochondria Function as a Therapeutic Strategy. | Genes (Basel) | 2021 | 34573330 | PubTator, text mining | PubMed |
| Role of Epigenetics in the Pathogenesis, Treatment, Prediction, and Cellular Transformation of Asthma. | Mediators Inflamm | 2021 | 34566492 | PubTator, text mining | PubMed |
| Oxidative Stress Genes in Diabetes Mellitus Type 2: Association with Diabetic Kidney Disease. | Oxid Med Cell Longev | 2021 | 34545296 | PubTator, text mining | PubMed |
| Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck. | Front Genet | 2021 | 34539737 | PubTator, text mining | PubMed |
| Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species. | Cell Metab | 2021 | 34536344 | PubTator, text mining | PubMed |
| Identification of the Ferroptosis-Associated Gene Signature to Predict the Prognostic Status of Endometrial Carcinoma Patients. | Comput Math Methods Med | 2021 | 34531924 | PubTator, text mining | PubMed |
| Ferroptosis Driver SOCS1 and Suppressor FTH1 Independently Correlate With M1 and M2 Macrophage Infiltration in Head and Neck Squamous Cell Carcinoma. | Front Cell Dev Biol | 2021 | 34527677 | PubTator, text mining | PubMed |
| Genome-wide mRNA profiling identifies the NRF2-regulated lymphocyte oxidative stress status in patients with silicosis. | J Occup Med Toxicol | 2021 | 34517882 | PubTator, text mining | PubMed |
| Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase. | Bioorg Med Chem | 2021 | 34507163 | PubTator, text mining | PubMed |
| Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2. | Bioorg Med Chem | 2021 | 34500187 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/239/papers?page=28